What is PathoGenetix has signed Sparton for manufacturing design and pilot production
Video inside here
PathoGenetix announced today that it has signed Sparton Corporation
as the design and manufacturing partner for the RESOLUTION™ Microbial Genotyping System. Under the terms of the agreement, Sparton will conduct design for manufacture and pilot production of a limited number of pre-commercial instruments for the RESOLUTION System, which is slated for commercial availability in 4Q2014.
The RESOLUTION System is the first commercial application of PathoGenetix’s proprietary Genome Sequence Scanning™ (GSS™) technology, and has been developed for food safety testing
in both the food industry and in public health foodborne illness outbreak investigations. The RESOLUTION System enables pathogen serotype identification and strain typing in just five hours, directly from complex mixtures such as enriched food and clinical samples. The bacterial strain information provided by the RESOLUTION System is comparable to pulsed field gel electrophoresis (PFGE), the current gold standard for pathogen typing in foodborne illness outbreak investigation and response.
Pre-commercial units of the RESOLUTION System are currently undergoing testing and evaluation by government and food industry partners. Earlier this month, PathoGenetix shipped a pre-commercial version of the RESOLUTION System to Marshfield Food Safety, LLC, under an agreement with the Wisconsin-based microbiology- and chemistry-testing laboratory to conduct independent testing and feedback on use of the RESOLUTION System for pathogen confirmation and identification in food industry applications.
